Bernstein analyst Lee Hambright maintained a Hold rating on Edwards Lifesciences on January 16. The company’s shares closed last Friday at $84.3...
Bernstein analyst Lee Hambright maintained a Hold rating on Edwards Lifesciences on January 16. The company’s shares closed last Friday at $84.3...